Recently, a new role of WDFY2 in cancer regulation is emerging; in fact, a CDKN2D-WDFY2 fusion transcript encoding a shorter WDFY2 protein was frequently found in ovarian cancer samples and associated with a deregulated expression of members of the PI-3K/AKT pathway [61]. The gene discussed is AKT1; the disease is ovarian cancer.